Breaking News
Apple Inc. has taken a major leap in wearable health technology after securing FDA approval for its latest hypertension monitoring feature on the Apple Watch Series 11 and Apple Watch Ultra 3. This cutting-edge blood pressure tracking capability will help users monitor their heart health, detect early signs of hypertension, and receive timely alerts through AI-powered analytics—all directly from their smartwatch.
The new feature was showcased at Apple’s highly anticipated Awe Dropping event on September 9, 2025. However, the rollout was pending regulatory clearance from the U.S. Food and Drug Administration (FDA), which the company received on September 11, 2025. The hypertension monitoring feature is expected to launch globally alongside the release of the iPhone 17 series and iPhone Air on September 19, 2025.
Designed to work seamlessly in the background, the Apple Watch will continuously track blood pressure trends and send notifications if long-term signs of high blood pressure are detected. This proactive monitoring approach could help prevent health complications by alerting users to consult healthcare professionals early. Apple estimates that this innovation may assist over 1 million people with undiagnosed hypertension within the first year of its release.
The new blood pressure monitor feature will be available in more than 150 countries, including the US, European Union, and others, although availability in India is yet to be confirmed. This development reinforces Apple’s commitment to integrating AI-driven health solutions, smart wearables, and personalized healthcare monitoring into everyday technology.
With this milestone, the Apple Watch continues to set the standard for fitness tracking, health analytics, and preventive care, making it an indispensable device for users prioritizing heart health and wellness in today’s fast-paced world.
The new feature was showcased at Apple’s highly anticipated Awe Dropping event on September 9, 2025. However, the rollout was pending regulatory clearance from the U.S. Food and Drug Administration (FDA), which the company received on September 11, 2025. The hypertension monitoring feature is expected to launch globally alongside the release of the iPhone 17 series and iPhone Air on September 19, 2025.
Designed to work seamlessly in the background, the Apple Watch will continuously track blood pressure trends and send notifications if long-term signs of high blood pressure are detected. This proactive monitoring approach could help prevent health complications by alerting users to consult healthcare professionals early. Apple estimates that this innovation may assist over 1 million people with undiagnosed hypertension within the first year of its release.
The new blood pressure monitor feature will be available in more than 150 countries, including the US, European Union, and others, although availability in India is yet to be confirmed. This development reinforces Apple’s commitment to integrating AI-driven health solutions, smart wearables, and personalized healthcare monitoring into everyday technology.
With this milestone, the Apple Watch continues to set the standard for fitness tracking, health analytics, and preventive care, making it an indispensable device for users prioritizing heart health and wellness in today’s fast-paced world.
See What’s Next in Tech With the Fast Forward Newsletter
Tweets From @varindiamag
Nothing to see here - yet
When they Tweet, their Tweets will show up here.
